Usability of TXI for diagnosing gastric cancer

Usability of Texture and Color Enhancement Imaging (TXI), image enhanced endoscopy system, for diagnosing gastric cancer: a prospective trial - Usability of TXI for diagnosing gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042429

Enrollment

Registered

2020-11-16

Start date

2020-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial gastric neoplasms

Interventions

Endoscopy (GIF-H290Z) Endoscopy (GIF-EZ1500 or GIF-XZ1200)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patients with present history of gastric neoplasms 2. Patients who agree with the informed consent.

Exclusion criteria

Exclusion criteria: 1.A Patient aged < 20 2. A patient who is pregnant 3. A lesion more than 8 cm 4.The patients who are evaluated inappropriate for the resear

Design outcomes

Primary

Measure	Time frame
Comparison of visibility for gastric neoplasms (white light imaging vs. TXI)	—

Secondary

Measure	Time frame
1. Visibility (GIF-H290Z vs. GIF-EZ1500 or GIF-XZ1200) 2. Correlation of characteristics of detectable or undetectable lesion in WLI or TXI 3. Detection rate in WLI or TXI 4. Inter-observer agreement	—

Countries

Japan

Contacts

Public ContactAkira Dobashi

The Jikei University School of Medicine Department of Endoscopy

ad99061@jikei.ac.jp03-0433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026